Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Am J Ophthalmol. 2019 Jan 14;200:242–249. doi: 10.1016/j.ajo.2019.01.004

Table 3.

Ocular findings amongst 141 children diagnosed with congenital myasthenic syndrome from 1966 through 2015 at Mayo Clinic

No. (%)
Ptosis Extraocular
movement
limitation
Strabismus Overall
N=141
Presynaptic N=11 7 (63.6) 2 (18.2) 2 (18.2)
 ChAT deficiency 1 1 1 1
 SNAP25B 1 0 0 1
 Unknown 5 1 1 9
Postsynaptic N=51 46 (90.2) 46 (90.2) 4 (7.8)
 Alpha subunit defect 1 2 0 2
 Beta subunit defect 3 3 0 3
 Delta subunit defect 1 1 0 1
 Epsilon subunit defect 9 9 1 9
 Slow channel 11 12 3 14
 Fast channel 2 2 0 2
 Unknown 19 17 0 20
Synaptic N=14 11 (78.6) 8 (57.1) 0 (0.0)
 Collagen Q mutation 1 0 0 1
 Laminin B2 deficiency 1 1 0 1
 Unknown 9 7 0 12
Endplate development and maintenance N=16 12 (75.0) 3 (18.8) 7 (43.8)
 Dok- 7 myasthenia 3 1 0 4
 Rapsn deficiency 8 2 7 11
 MuSK deficiency 1 0 0 1
Defects of glycosylation N=1
 DPAGT1 myasthenia 0 0 0 1
Indeterminate N=48 36 (75.0) 22 (45.8) 8 (16.7) 48